Skip to main content
    H

    Harrow Health Inc (HROW)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $29.52
    +0.43 (+1.48%)

    Market Cap: $1.09B

    Last updated: Nov 17, 2026 at 4:24 PM ET

    Harrow Health Inc (HROW) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Harrow Health (HROW) has a latest price of $29.52 on Nov 17, 2026, 46.2% below its 52-week high of $54.85. Its price fell 27.6% over the past 12 months. The month-end price rose 951.8% over the 10 years through Oct 2026, a compound annual rate of 26.5%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $54.18 in Feb 2026 and its lowest $1.50 in Oct 2017, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart HROW with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for HROW.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 29.1%, and over 6 months it fell 3.8%. The month-end price rose 97.0% over the 3 years through Oct 2026, a compound annual rate of 25.4%.

    PeriodChange
    1 month+6.6%
    3 months-29.1%
    6 months-3.8%
    12 months-27.6%
    12 months, with dividends-27.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+97.0%+25.4%
    5 years+179.9%+22.9%
    10 years+951.8%+26.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2018, when the price rose 234.7%, and its weakest was 2017, when it fell 32.0%.

    YearCloseChange
    2026 through Oct 2026$28.24-42.4%
    2025$49.00+46.1%
    2024$33.55+199.6%
    2023$11.20-24.1%
    2022$14.76+70.8%
    2021$8.64+25.9%
    2020$6.86-11.8%
    2019$7.78+36.7%
    2018$5.69+234.7%
    2017$1.70-32.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 3.0% below its 50-day average of $30.42 and 21.0% below its 200-day average of $37.37.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$29.52
    52-week high$54.85-46.2%
    52-week low$25.76+14.6%
    50-day average$30.42-3.0%
    200-day average$37.37-21.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 61.4%.

    MeasureValue
    1-year beta1.42
    Largest fall, 1 year-52.5%
    Largest fall, 3 years-61.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About HROW

    What is HROW's 1-year price change?

    Harrow Health's price fell 27.6% over the past 12 months. With dividends included, the 12-month total return was -27.6%.

    What is HROW's 5-year price change?

    Harrow Health's month-end price rose 179.9% over the 5 years through Oct 2026, a compound annual rate of 22.9%. These figures leave out dividends.

    What is HROW's 52-week high and low?

    Harrow Health's 52-week high is $54.85 and its 52-week low is $25.76. Its latest price of $29.52 on Nov 17, 2026 is 46.2% below the high.

    What is HROW's beta?

    Harrow Health's 1-year beta against the S&P 500 is 1.42, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 52.5%.

    Is the HROW chart free?

    Yes. Advanced Charting for HROW is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.